Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -39.03%8.08B | 5.96%53.48B | 39.34%13.25B | -6.23%50.47B | 35.07%18.44B | -5.44%10.77B | -17.17%11.75B | -34.82%9.51B | 6.23%53.82B | 10.31%13.65B |
| Cost of revenue | -30.11%5.93B | 4.02%33.57B | 32.62%8.48B | -7.83%32.27B | 26.03%11.19B | -11.36%6.68B | -11.55%8.01B | -33.00%6.39B | 9.37%35.01B | 13.28%8.88B |
| Gross profit | -54.88%2.15B | 9.39%19.91B | 53.13%4.77B | -3.25%18.2B | 51.89%7.25B | 6.15%4.09B | -27.07%3.75B | -38.25%3.12B | 0.83%18.81B | 5.17%4.77B |
| Operating expense | 6.80%2.74B | 15.63%11.03B | 16.60%2.56B | 8.72%9.54B | 18.40%2.66B | 9.10%2.4B | 6.76%2.28B | 0.32%2.2B | 22.70%8.77B | 7.88%2.25B |
| Operating profit | -126.28%-581.39M | 2.52%8.88B | 140.27%2.21B | -13.70%8.66B | 81.72%4.59B | 2.22%1.69B | -51.13%1.47B | -67.79%920.92M | -12.76%10.04B | 2.88%2.52B |
| Net non-operating interest income (expenses) | -144.04%-746K | 35.41%99.98M | -51.56%1.69M | 365.97%73.83M | 1,913.62%45.27M | 295.31%14.66M | 255.09%10.41M | 131.66%3.5M | -12.53%-27.76M | 74.90%-2.5M |
| Non-operating interest income | 20.98%26.64M | 31.38%191.31M | 1.77%22.02M | 243.21%145.62M | 303.30%63.2M | 198.14%32.36M | 143.60%28.43M | 410.81%21.63M | 53.23%42.43M | 289.22%15.67M |
| Non-operating interest expense | 34.74%27.38M | 27.23%91.34M | 12.05%20.32M | 2.28%71.79M | -1.30%17.93M | -3.55%17.71M | -2.00%18.02M | 18.68%18.14M | 34.05%70.19M | 30.04%18.17M |
| Net investment income | -275.06%-226.28M | -37.68%100.38M | -29.91%129.26M | 401.50%161.08M | 342.67%85.46M | 61.53%-198.15M | -62.68%89.34M | -46.22%184.43M | -61.99%32.12M | -121.63%-35.22M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 10,222.23%1.29B | -12.79M | 0 | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 88.33%-2.03M | 2,610.95%480.63M | -193.73%-17.43M | 133.89%17.73M | 77.53%-9.29M | 88.97%27.85M | 138.93%5.1M | 52.96%-5.93M | 41.55%-52.31M | 35.22%-41.33M |
| Less:Impairment of capital assets | ---- | 8.84%33.08M | 8.78%8.08M | 2.37%30.4M | ---- | ---- | ---- | 2.12%7.42M | 12.47%29.69M | ---- |
| Less:Other special charges | -78.25%2.03M | -967.42%-513.71M | 727.65%9.35M | -312.79%-48.13M | -281.37%-21.11M | -132,719.05%-27.85M | -58.64%2.32M | -127.88%-1.49M | 48.18%22.62M | 27.33%11.64M |
| Other non-operating income (expenses) | -10.56%76.15M | 65.29%352.7M | 124.89%85.15M | 9.83%213.39M | -13.84%75.03M | 70.47%51.3M | 30.37%49.2M | -3.85%37.86M | 4.61%194.29M | 128.82%87.08M |
| Income before tax | -130.45%-734.3M | 22.96%11.21B | 111.38%2.41B | -10.49%9.12B | 88.40%4.77B | 34.97%1.58B | -50.26%1.62B | -64.55%1.14B | -12.93%10.18B | -3.16%2.53B |
| Income tax | -128.49%-205.42M | 15.59%3.09B | 101.47%720.91M | -5.65%2.67B | 75.12%1.44B | 39.33%428.5M | -47.29%446.12M | -58.18%357.83M | -20.13%2.83B | -24.84%821.39M |
| Net income | -131.29%-528.87M | 26.02%8.12B | 115.90%1.69B | -12.35%6.44B | 94.78%3.33B | 33.41%1.15B | -51.31%1.18B | -66.86%782.95M | -9.80%7.35B | 12.40%1.71B |
| Net income continuous operations | -131.29%-528.87M | 26.02%8.12B | 115.90%1.69B | -12.35%6.44B | 94.78%3.33B | 33.41%1.15B | -51.31%1.18B | -66.86%782.95M | -9.80%7.35B | 12.40%1.71B |
| Noncontrolling interests | 0 | 0 | 0 | -72.79%5.8M | -155.77%-4.73M | |||||
| Net income attributable to the company | -131.29%-528.87M | 26.02%8.12B | 115.90%1.69B | -12.28%6.44B | 94.24%3.33B | 33.68%1.15B | -51.22%1.18B | -66.79%782.95M | -9.63%7.35B | 13.35%1.72B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -131.29%-528.87M | 26.02%8.12B | 115.90%1.69B | -12.28%6.44B | 94.24%3.33B | 33.68%1.15B | -51.22%1.18B | -66.79%782.95M | -9.63%7.35B | 13.35%1.72B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -131.28%-7.05 | 26.05%108.28 | 116.11%22.54 | -12.25%85.9 | 94.41%44.4218 | 33.84%15.3867 | -51.22%15.67 | -66.81%10.43 | -9.66%97.8967 | 13.29%22.85 |
| Diluted earnings per share | -131.28%-7.05 | 26.05%108.28 | 116.11%22.54 | -12.25%85.9 | 94.41%44.4218 | 33.83%15.3865 | -51.24%15.6589 | -66.81%10.43 | -9.66%97.8967 | 13.30%22.85 |
| Dividend per share | 0 | 50.00%20 | 0 | 0.00%13.3333 | 0.00%13.3333 | 0 | 0 | 0 | 0.00%13.3333 | 0.00%13.3333 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |